New Leaf Venture Partners, L.L.C. Aptinyx Inc. Transaction History

New Leaf Venture Partners, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Jun 04, 2019	SELL	$3.99 - $19.33 $970,946 - $4.7 Million	-243,345 Reduced 6.89%	3,290,079 $13.3 Million
Q1 2019 May 15, 2019	BUY	$3.99 - $19.33 $970,946 - $4.7 Million	243,345 Added 7.4%	3,533,424 $14.3 Million
Q2 2018 Aug 14, 2018	BUY	$19.83 - $24.17 $65.2 Million - $79.5 Million	3,290,079 New	3,290,079 $79.5 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.